Sensitizing Triple-Negative Breast Cancer to PI3K Inhibition by Cotargeting IGF1RKlaas de Lint(Oncode Institute), Roderick L. Beijersbergen(Oncode Institute)Molecular Cancer TherapeuticsMay 12, 201610.1158/1535-7163.mct-15-0865Cited by 40SaveCiteExport RISWatch citationsRelated PapersAn shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors|Nature Chemical Biology|2006|188The Histone Demethylase Jarid1b (Kdm5b) Is a Novel Component of the Rb Pathway and Associates with E2f-Target Genes in MEFs during Senescence|PLoS ONE|2011|50